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Hormonal analyses have become indispensable for
managing high-risk pregnancies. They allow an
early diagnosis of chronic disturbances in the
nutritive function of the placenta and of fetal
growth retardation. However, except for a few
clinics [2, 9] hormonal assays are frequently used
only when the placental dysfunction is already
clinically manifest (premature labor, discrepancy
between uterine size and estimated gestational age,
etc.) or if there are serious risk factors from the
history. Not infrequently "placental insufficiency"
is not accompanied by any clinical Symptoms [10,
18] and thus escapes diagnosis, or at least early
diagnosis. Early diagnosis, however, is the decisive
prerequisite for successful therapy which must
have its goal a mature healthy newbom with a
normal birth weight.
Biochemical parameters in contrast to clinical and
biophysical obstetric indicators are currently the
only ones which give any direct Information about
the function of the placenta. Measurements of
placental perfusion with radioisotopes cannot be
used in clinical routine äs yet. Therefore, hormonal
assays should indicate disturbances in placental
function earlier than the other variables. Thus, the
medically correct procedure would consist of
*Presented in part at the 41 st meeting of the German
Society for Gynecology and Obstetrics, Hamburg,
September 28 to October 2,1976.
hormonal assays for all pregnant women äs a
preventive measure, thus facilitating either ex-
clusion or early diagnosis of a placental risk. A
suitable endocrine surveillance program for
pregnant patients prior to the 30 th week leading
to a marked decrease of the number of small-for-
dates infants has not been described to date.
We have recently published an endocrine model
[18] in which we postulate that generally there is a
primary impairment of placental function and that
fetal manifestations are secondary (except for
primary fetal anomalies). An endocrine surveillance
program for the early recognition of placental
functional disturbances should therefore primarily
utilize placental indicators. The estrogen excretion
in the urine äs well äs the estriol concentration in
the plasma is an early fetal but not an early
placental indicator [9,18]. Therefore, we Interpret
pathological excretions of estrogen äs representing
already present fetal damage and consequently we
attempt to avoid this advanced stage of disturbed
fetoplacental function. A suitable early placental
indicator in our experience is the urinary excretion
of pregnanediol [18] and somewhat less the concen-
tration of human placental lactogen (HPL) in
the serum [WOLFRUM, to be published]. The
present study attempts to give further proof of the
usefulness of the described model. Thus the
determination of total estrogen was included in
the program. In addition, the study was to answer
threequestions:
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l.What is the earliest time at which "placental
insufficiency" can be diagnosed by means of
pregnanediol excretion?
2. Is it possible to predict the future function of
the placenta and the further growth of the fetus
from hormonal fmdings between the 20 th and
30th week of gestation?
3. Is it possible to decrease significantly the number
of premature and dysmature births by early
diagnosis and appropriately timed preventive
measures?
l Material and Methods
Analytical methods described earlier [19, 20] and
controls [18] were used. The preventive program
admitted at no cost pregnant women who were at
least in the 19th and not beyond the 23 rd week of
gestation. Delivery in our hospital was not a
condition for acceptance into the program. The
contact with patients was maintained through an
informational brochure via the practicing obstetri-
cians. Each patient had a determination of the
biparietal skull diameter by udtrasound in Order to
verify the estimated date of confinement. If the
calculated gestational age from the last menstrual
period and the ultrasonographic findings deviated
from each other by more than two weeks, the
patient was measured again with ultrasound four
weeks later. At the first clinic visit each patient
was extensively informed about the purpose of the
program and the technique of urine collections.
After the ultrasonography , three comb ine d estrogen
and pregnanediol determinations were carried out
at intervals of two weeks. Thus, the program
extended from the 20th to the 27th week of
gestation.
Pregnanediol excretion was considered pathological
if at least two of the three values were below the
potentially pathologic ränge (Fig. 1).
The estrogen excretion was considered pathological
l . either at least two of the three values were in
the potentially pathological ränge or below and
if the excretion did not increase, or
2. if all three values were below the potentially
pathological ränge, or
3. if there was a successive decrease in the excretion
within the normal ränge.
With an Interpretation of either the pregnanediol
excretion or the estrogen excretion alone äs
pathological the entire analysis was considered
abnormal. If the hormonal findings were normal,
the patient was not further examined unless there
was ahigh-riskhistory. With pathological hormonal
results the patients were monitored further but at
shorter time intervals (1—3 hormonal assays per
week including HPL determination and biweekly
ultrasonography including thorax diameter).
Between the 30th and 33rd week the hormonal
patterns were evaluated again. Patients with in-
creased pathological hormonal findings and clinical
risk factors (toxemia, etc.) were cared for in an
intensive special program until delivery; they
accounted for about 10% of the total group and
willbereported on separately. "Borderline" findings
without clinical symptomatology did not lead to
intensive monitoring; these patients were given
general preventive advice such äs stopping to work,
mg/24h Pregnanediol,'
20 24 28 32 36 40
weeks of pregnancy
Fig. 1. Examples of pathological hormonal excretion äs
defined in the text. The curves represent estrogen and
pregnanediol values from six separate pregnancies.
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avoidance of stress, and proscription of smoking
but there were occasional hormonal and ultra-
sound controls.
We define "placental risk" äs follows:
l.History: one or more perinatal deaths (except
for unequivocally non-placental causes of
death) or one or more children with a birth
weight of equal to or under 2700 grams or two
or more abortions or severe toxemia.
2.Current pregnancy: placental weight less than
500 g* or macroscopically markedly infarcted
placenta orpathological findings in the placental
histology** or hypertension in early preg-
nancy*** or threatened abortion or elderly
primipara (over 32 years) or elderly multipara
(over 40 years) or young primipara (under 20
years). The presence of even one risk factor from
history or current pregnancy was considered äs
indicative of "placental risk." Only one factor
was applied to each patient. If several factors
were present, the clinically more severe was
used: current pregnancy over past pregnancies,
dead fetus over hypotrophic fetus, hypotrophic
fetus over toxemia, placental weight or abnormal
histology over hypertension, etc.
The results of the hormonal assays were statisti-
cally related to birth weight and "placental risk."
The surveillance program exists since early 1974;
therefore, we compared premature and dysmature
births in our clinic from 1973 to 1975 in order to
determine any change in the outcome during that
time.
Statistical calculations used the chi square test for
normal distribution, the four fild chi square test,
and the t-test.
To determine the gestational age and maturity of
the infant in the surveillance group we utilized the
ultrasound findings (biparietal skull diameter)
from the 19 th to 20th week, the maturation index
* Mean placental weight: 600 grams (N = 396 pregnant
patients from the above described group; Range 260-
960g).
** We are indebted for placental morphology to Professor
Dr. H.-E. STEGNER, Head, Section for Gynecological
Histopathology and Electron Microscopy, Department of
Obstetrics and Gynecology, University of Hamburg.
*** Toxemia occuring during and other factors late preg-
nancy which are difficult to assess such äs smoking, stress,
etc. were not considered.
of PETRUSSA [15] and also the menstrual histoiy.
In all other cases the menstrual history was used
primarily äs well äs length [13] and head circum-
ference [13] of the infant for determination of
maturation. The boundary between appropriate-
for-dates newborns and small-for-dates infants is
generally taken to be the lOth percentile of
LUBCHENCO [13]. For infants bom at 40 weeks
this is 2600 grams. Some newer findings from
Europe [3, 12, 14] have shown that the limit in
this social, economic, geographic and ethnical
environment is higher [9]. In order to account for
this fact and to make comparisons possible [9] we
drew the limit at 2700 grams. This corresponds to
the 15th percentile of Lubchenco. Locally appli-
cable percentiles are not yet known. Newborns
from the beginning of the 38th week were con-
sidered äs mature [9]. Otherwise newborns with
a weight of equal to or under 2700 grams were
classified äs described by KLINGMÜLLER-AHTING
et al. [9] äs hypotrophic mature, eutrophic pre-
mature, and hypotrophic premature. Corre-
spondingly, the 15th percentile of Lubchenco was
used. Twins were excluded from these statistics.
2 Results
2.1 Correlation between birth weight and
hormonal assays
The birthweights of the infants with normal
assays and of those with pathological results of
hormonal assays were tested with the chi square
test äs to normal distribution. It was found that
for the group with pathological hormonal assay,
2
 = 5.443. The significance threshold for p = 0.05
for 5 degrees of freedom is 2 = 11,070. For the
group with normal hormonal assay it was found
that 2 = 5,004. The level of significance for
p = 0.05 for 8 degrees of freedom is 2 = 15.507.
Thus the distribution of frequency for the birth-
weights in both groups can be considered äs normal
and consequently the t-test may be used for a test
of significant differences. The average birth weight
of all children with normal hormonal findings was
3468 grams, for those with pathological results it
was 3210 grams. The difference in the t-test is
highly significant (p < 0.001). This expresses the
fact that in the group with pathological hormonal
findings children with relatively low birth weights
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Fig. 2. Three combined estrogen and pregnanediol deter-
minations in 500 pregnant patients between the 20 th and
27th week. The 500 newborns are classified in five weight
categories (five dual columns). In each weight category
infants from pregnancies with pathological hormonal
assays (hatched columns) are compared with those from
pregnancieswithnormalhormonalfindings(blank columns).
are over-represented. Obviously, a pathological
hormonal assay does not in every case predict a
low birth weight infant. feesults are summarized
in Tab. I and Fig. 2.
2.2 Correlation of "placental risk" with hormonal
assay findings
Among the 500 pregnancies of the surveillance
program there were 208 (41.6%) with "placental
risk." The classification äs to the separate factors
is given in Tab. II.
About 25% of all pregnancies are risk pregnancies
[16]. If the placental contribution is estimated äs
two-thirds then it is seen that our surveillance
program did not deal with an ünselected group
since it comprises in comparison to a hypothetical
normal cohort iriore than twice the proportion of
placental risk cases. We found 381 cases of normal
hormonal excretiön, 105 cases of pathological
pregnanediol excretiön, 4 times pathological estro-
gen and pregnanediol excretiön (Tab. I). The
endocrine Status was thus pathological in 119
cases (23.8% of all pregnancies).
Tab. I. Classification of pregnancies into risk groups according to the combined estrogen and pregnanediol excretiön.
Mean birth weight is correlated with hormonal findings. Cases with "placental risk" are correlated to hormonal findings.
The frequency of hypotrophic newborns and eutrophic prematures is indicated.
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After the very highly significant correlation
between pregnanediol excretion and nutritive
placental function had been found, we tested with
the four field χ2 test whether the group with
pathological hormonal findings contained signifi-
cantly more "placental risk" (70 times = 58.8% of
our cases with pathological hormonal findings)
than the group with normal hormonal Status
(138 times = 36.2% of all cases with normal
hormonal findings). The test is highly significant
(p < 0.001).
In combination with the positive correlation
between birth weight and hormonal findings, it is
thus shown thatthe named "placental risk factors"
are indeed placental risk factors with a potential
impairment of the nutritive function. These results
are summarized in Tab. I. According to our model
most of the later hypotrophic newborns (10 of
15) | are still in risk group II (only pathologi-
cal pregnanediol findings) at this stage of preg-
nancy.
In 48 cases there was no "placental risk", yet the
hormonal findings were thought to be pathological
(40.3% of all pathological hormonal findings). Of
these pregnancies 45 ended with the birth of a
mature,normal-weightinfant,one with prematurity,
and two with dysmaturity.
Cases with "placental risk" in the history and
currently normal findings were analysed separately.
There were 41 such pregnancies. It was seen that
with normal hormonal findings in 39 cases (95.1 %)
a mature, normal-weight child was born (one
eutrophic premature with 2500 grams/47 cm and
a hypotrophic mature with 2650 grams/48 cm).
Cases with normal hormonal Status resulting in a
low weight infant were analysed separately. There
were 17 such pregnancies (3.4%). In 14 cases
(2.8%) the children were eutrophic prematures
and in 3 cases (0.6%) hypotrophic mature infants
(2460 g, 2650 g, 2700 g). The number of falsely
normal hormonal assays resulting in hypotrophic
newborns thus is less than l%of all births (16.6%
of all hypotrophic newborns). The distribution of
hypotrophic newborns and eutrophic prematures
in risk group I and II—IV is shown in Tab. I.
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2.3 Comparison of premature and dystrophic
infants
After the high predictive accuracy for diagnosis
and prognosis in our surveillance program had been
established we were interested in determining how
the number of prematures and dystrophics had
changed since the initiation of the program. For
this purpose all deliveries in our hospital in 1973
were compared with those of 1974 and 1975. The
newborns of the surveillance program were analysed
äs a separate group. For all groups infants with a
birthweight of equal to or less than 2700 grams
were classified äs either hypotrophic mature infants,
eutrophic prematures, or hypotrophic prematures.
Results are summarized in Tab. III.
For comparison with World Health Organization
criteria, a column with infants weighing equal to or
less than 2500 grams is included. Column 4, lines
l, 2, 3 of Tab. III demonstrates that the total
number of all low birth weight infants in our
hospital between 1973 (8.6%) and 1975 (8.2%)
remained virtually unchanged. A classification into
the three subgroups (columns 5 a-c, 4d, lines 1,2,
3) shows that the number of prematures increased
significantly (p <0.01)between 1973 and 1974 but
decreased weakly significantly (p < 0.1) between
1974 and 1975; there is a slight nonsignificant
increase from 1973 to 1975. However, the number
of dystrophic births since 1973 has continued to
drop. The decrease between 1973 and 1975
(column 5d, lines l and 3) is weakly significant
(p <0.1). From column 4,lines l, 2,3,4 it is seen
that the total number of low birth weight infants
in the surveillance group'is lower than the corre-
sponding total group (difference to 1973 and to
1975 not significant, but highly significant to
1974). From the classification into the 3 sub-groups
it can be seen, that the surveillance group has
significantly fewer prematures äs compared to the
total group in 1974 (p < 0.01) and 1975 (p < 0.1)
respectively. The number of dystrophic infants
between the surveillance group and the entire
group in 1973, 1974, and 1975 is not significantly
different. Considering the decrease in dystrophic
births from 1973 to 1975 this fact expresses that
because of the increased "placental risk" the
dystrophic births are increased in the surveillance
group. Statistics of 1868 newborns from 1975 in 3
other obstetric Services in Hamburg [17] showed
that about 9.7% of the infants born in Hamburg in
1975 weighed equal to or less than 2700 grams. Of
these about 4.2% were eutrophic prematures and
about 5.5 %werehypotrophicmature and premature
infants. Thus, our surveillance group and the average
in Hamburg did not differ significantly in respect
to premature infants (p > 0.1). In respect to pre-
matures, our total group in 1975 was slightly
(p <0.1 %) above the Hamburg average. The number
of dystrophic births in our surveillance group
(3.6%) is slightly (p < 0.1) less than the Hamburg
average but in the total group (2.6%) the difference
is markedly significant (p < 0.001).
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3 Discussion
From our recentiy described endocrine model [18]
it may be expected that a pathological hormonal
Status between the 20th and 27th week shoiüd
primarily consistof abnormal pregnanediol findings.
In 105 women (88.2%) of a total of 119 with patho-
logical hormonal Status the pregnanediol excretion
only was pathological. Thus,our expectations were
confirmed and our model was further corroborated.
There is a highly significant correlation between
the presence of "placental risk" (Tab. ) and the
hormonal Status (Tab. I) äs well äs between mean
birth weight and hormonal Status (Tab. I). Thus, it
has been further proven that pregnanediol excretion
äs determined by our method [20] represents a
very sensitive early indicator of decreased nutritive
placental function. This result is the more sur-
prising since most authors [l, 8,11 and others] do
not consider pregnanediol excretion äs a suitable
indicator of nutritive placental function. Whether
the contradictory experiences of other authors
with pregnanediol are based on the variations in
methodology must await further investigation.
With the aid of pregnanediol excretion the diagnosis
of beginning "placental insufficiency" can bemade
äs early äs between the 20 th and the 27 th week. In
this stage of pregnancy the fetus is normally not
yet impaired in his growth and consequently
estrogen excretion is usually within the normal
ränge. The hormonal Status in only three cases of
hypotrophic newborns (16.6% of all hypotrophic
infants or 0.6% of all newborns of the surveillance
group) was normal between the 20 th and 27 th
week. Even if the pregnancies did show a "placental
risk" they resulted in 39 of 41 cases in a normal
mature infant if the hormonal Status was normal.
From this and from the very highly significant
correlation between mean birth weight and
hormonal Status it follows that the hormonal
findings between the 20 th and 27 th week do not
only give an Information about the actual functional
state of the placenta but also allow a relatively
accurate prognosis about the further course of
pregnancy and fetal growth.
However, this includes a relatively high proportion
of "false pathological" hormonal findings. It is
difficult to assess how high this proportion actually
is. In addition to methodological limitations and
uncertainties (losses during the analytical proce-
dure) which cannot be abolished entirely, a "false
pathological" hormonal Status can also be explained
on morphological reasons. It is known that the
placenta has considerably capabüities for compen-
sation i.e. morphologically in particular the ability
of the new formation of endocrine active syncytio-
trophoblast from LANGHANS' cells [5, 6, 7].
Possibly this finds an endocrine expression in
(insufficient syncytiotrophoblast) later becomes
normal or tends towards normalization äs has been
observed by us [18]. Even a failure of pregnanediol
excretion to normalize does not necessarily indicate
a clinically manifest fetal growth retardation. In
cases of pathological pregnanediol excretion during
the entire second half of pregnancy with simul-
taneously normal weight infants we usually observe
a normal estrogen rise until deliveiy. Evidently,in
these cases the residual capacity of the placenta is
sufficient for normal fetal supply. Thus, it is
possible that our patient groups contain a higher
number of these mild, possibly transient forms of
placental insufficiency because in comparison to a
hypothetical group of randomily selected patients
more thantwice the number of cases with "placental
risk" are included in the survey. This indicates a
certain selection of the patients by the referring
obstetricians who collaborated with us even though
a selection was not initially planned. A clinically
unremarkable course of pregnancy or the normal
weight of a newbom do not prove that the placental
function has been entirely normal throughout. It
is obviously important for obstetric management
that the number of "false normal" findings is low.
This condition is met by our program.
It would be desirable to carry out endocrine
surveillance in all pregnancies between the 20th
and 30th week at a time when the placental
indicators are of particular significance. After the
30th week, estrogen excretion äs an indicator of
fetal growth assumes greater importance without
any doubt.
The total number of prematures in our hospital was
not significantly decreased by the endocrine sur-
veillance, even though the surveillance group did
contain significantly less prematures than the total
patient population in 1974 and 1975 (Tab. III).
We had determined earlier [18] that there is not
J. Perinat. Med. 5 (1977)
140 Wolfrum et al., Combined assay of total estrogen and pregnanediol in urine
always a correlation between premature onset of
labor and the excretion of hormones. It is remark-
able, however, that the prematures with normal
hormonal Status were most typically eutrophic
premature (Tab. I). Evidently, in these cases, the
premature onset of labor is not brought on by a
utero-placental insufficiency, but possibly more by
aneuroexcitatory hypersensibility [4]. The primary
indication for hormonal analysis is the diagnosis of
chronic impairment of nutritive placental function.
Therefore, one should expect from an endocrine
surveillance program, a decrease in the number of
dystrophic births. We were able to prove that
(Tab. III, column 5d, lines, 1,2, 3). Our results to
the best of our knowledge also represent the only
tabulation in which there is a marked decrease of
hypotrophic newborns between 1973 and 1975.
We consider two factors äs responsible: early diag-
nosis by determination of pregnanediol excretion
after the 20 th week and tesiuting timely long-term
preventive measures.
There is a wide-spreadopinion that hormonal assays
in 24 hour urines are not practicable in ambulatory
practice because of the uncertainty of proper
collecting techniques. We do not find this to be
true. The number of hormonal assays which could
not be analysed properly because of faulty urine
collections in our study (äs identified by creatinine
determinations) is negligibly low. In our experience
only two conditions need to be met in order to
demonstrate practicability in this respect: l. there
must be no languäge barriers; 2. the patient must
be motivated. There should be littie argument that
pregnant women are pärticularly easily motivated.
Summary
The prognostic value of hormonal assays in pregnant
women during the second trimester in regard to the risk
for premature and dysmature births was studied. Based on
a recently published endocrine model, since early 1974
we performed three combined total estrogen and preg-
nanediol assays in the 24 hour urine in 500 "unselected"
women between the 20th and 27 th week of gestation.
We believe this to be the first description of a systematical
endocrine surveillance program in this early stage of
gestation. The current study uses afundamentauy different
approach than has been used thus far in perinatal medicine,
where hormonal assays are carried out only after the 30th
week of gestation. These then left often only the decision
whether the pregnancy should be terminated prematurely.
Thus, intrauterine fetal death but not intrauterine growth
retardation and frequently associated irreversible brain
damage of the infant might be avoided. This procedure
represents a dead-end street in so far äs it may aid in
lowering perinatal mortality but not perinatal morbidity.
The early starting point of our surveillance (20 th week)
was chosen because we think that premature termination
of pregnancy is not necessarily the only consequence when
dealing with "placental insufficiency." If this emergency
solution is to be avoided, two prerequisites must be met:
1. early diagnosis of placental functional disturbance and
2. timely long-term preventive measures. Hormonal
diagnosis, in our opinion, is currently the only chance for
early recognition of disturbed nutritive placental function
acceptable to large scale use. All other indicators (ultra-
sound, fundus height, etc.) show pathological results only
after the disturbed growth of the fetus is already manifest
and time for treatment has passed.
Gestational age was measured by means of ultrasonographic
determination of the biparietal skull diameter in the 20 th
week. Hormonal assays were divided into two groups,
normal and pathological. With normal hormonal assays
the patient was further monitored endocrinologically only
if there were concurrentclinicäl placental risk factors. With
pathological hormonal findings the assays were repeated
during a following control period of several weeks. Women
with increased pathological findings (10% of the total
group) were further cared for in an intensive program and
will be reported on separately. Hormonal findings were
statistically correlated to the birth weight of the children
and a defined "placental risk" from history or current
pregnancy. We then compared internally our premature
and dysmature births from 1973 to 1975. For thispurpose
the children equal to or under 2700 grams were classified
äs hypotrophic mature, eutrophic premature and hypo-
trophic premature. This study had the following results:
1. The endocrine model described by us was again con-
firmed. From the pathological hormonal findings 8 8.2%
were due to pathological pregnanediol excretion
(N ^ 105), only 3.3% (N = 4) due to pathological
estrogen excretion, the remainder (N = 10) had both
pathological estrogen and pregnanediol excretion. Thus,
the endocrine surveillance was 119 times pathological
(23.8% of all pregnancies, Tab. I).
According to our model fetuses who later become hypo-
trophic in this early stage of pregnancy usually are in
risk group II (10 of 15). There were too few cases to
allow percentage calculations^of the hypotrophic new-
borns in correlation with the corresponding risk groups.
However, äs early äs the 20th to 27 th week, the same
risk tendencies are recognizable äs have been recently
described for a group of 222 pregnant patients in later
stages of pregnancy: the risk of intrauterine growth
retardation increases markedly from risk group I (0.7%
hypotrophic infants) via II (10 of 105 newborns
hypotrophic) and III (one newborn off our hypotrophic)
to risk group IV (four newborns of 10 hypotrophic).
2. There is a highly significant correlation between preg-
nanediol excretion by our method and the mean birth
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weight of the newborns (Tab. I). This is further proof
that pregnanediol excretion by our method is an early
indicator of diminished nutritive placental function. By
measuring pregnanediol excretion "placental insuffi-
ciency" can be diagnosed äs early äs between the 20 th
and27th week.
3. A "placental risk" is defined from the patient's past
history of placental risk factors and those during the
current pregnancy (Tab. II). This "placental risk" is
found significantly more often associated with a
pathological hormonal assay than with normal hor-
monal assay (Tab. I). This association together with the
positive correlation between pregnanediol excretion
and mean birth weight prove that these factors of
"placental risk" indeed are risk factors related to the
placenta such äs potentially early diminished nutritive
function.
With "placental risk" in the past history and currently
normal hormonal assay, 39 of 41 (95.1%) infants were
born mature and with a normal weight (there was one
premature and one dystrophic newborn). In the
absence of a "placental risk" but with pathological
hormonal findings there were normal infants in 45 of
48 cases (93.7%) (one premature and two dystrophic
births).
4. In only 3 (16.6%) of 18 cases of hypotrophic newborns
the hormonal results in the second trimester were
normal. In contrast the hormonal findings in 14 of 17
cases (82.3%) of eutrophic prematures was normal.
5. Points 2, 3, and 4 above allow the conclusion that in
case of normal hormonal findings between the 20 th
and 27 th week a placental risk and thus the risk of
intrauterine growth retardation may be ruled out with
a high degree of certainty. With pathological hormonal
findings in the surveillance period it is necessary to
repeat the tests during the following weeks (control
period) and to select between the 30 th and 33rd week
those cases in which impairment of the fetus must be
assumed. The latter require an intensive program until
delivery.
6. The system described allows an early diagnosis of
disturbed nutritive placental function and thus timely
preventive measures. These include in addition to the
treatment of clinical Symptoms, general rest and
decreased stress to the woman even before the 30 th
week, possibly longer periods of bed-rest if necessary.
The incidence of hypotrophic newborns in our hospital
decreased noticably from 1973 to 1975 (Tab. III). It
was not possible to decrease the number of eutrophic
prematures.
The incidence of prematurity in 1975 when compared
between our hospital (5.6%) and the average in our
region (about 4.2%) is not significantly different.
However, the difference in the number of dystrophic
newborns in 1975 between our hospital (2.6%) and the
average in Hamburg (about 5.5%) is significantly
different (p < 0.001).
7. An ambulatory endocrine surveillance program utilizing
24 hour urine collectionsis practicable if two conditions
are met: 1. there must be no language barrier with the
patient, and 2. the patient must be informed and
motivated.
8. We consider the results of this study a strong argument
in favor of extending the protective period provided
for pregnant women in the occupational health
regulations of the Federal Republic of Germany.
Keywords: Endocrine surveillance program, intrauterine growth retardation, nutritive placental function, pregnanediol,
total estrogens.
Zusammenfassung
Prognostischer Wert der kombinierten Gesamtöstrogen-
und Pregnandiolbestimmung im 24-Stunden-Urin, demon-
striert an 500 Schwangerschaften eines endokrinologischen
Vorsorgeprogramms im II. Trimenon
Es wird über eine systematische Studie zur Prüfung des
prognostischen Wertes von Hormonanalysen bei Schwan-
geren im II. Trimenon hinsichtlich des Risikos der Früh-
und Mangelgeburt berichtet. Auf der Basis eines kürzlich
veröffentlichten endokrinologischen Modells wurden seit
Anfang 1974 bei 500 „unausgewählten" Schwangeren
zwischen der 20. und 27. Schwangerschaftswoche drei
kombinierte Gesamtöstrogen- und Pregnandiolbestimmun-
gen im 24-Stunden-Urin durchgeführt. Es handelt sich
unseres Wissens um die erstmalige Beschreibung eines
systematischen endokrinologischen Vorsoigeprogramms
aus diesem frühen Schwangerschaftsstadium. Die vor-
liegende Studie beschreitet damit einen prinzipiell anderen
Weg als es bisher in der Perinatalmedizin üblich war. Be-
kannterweise werden Hormonanalysen meist erst nach der
30. Schwangerschaftswoche durchgeführt. Sie dienen dann
oft nur der Entscheidung, ob die Schwangerschaft vorzeitig
beendet werden muß oder nicht. Dadurch können zwar
der intrauterine Fruchttod, jedoch nicht die intrauterine
Wachstumsverzögerung und die damit häufig verbundenen
irreversiblen zerebralen Schäden des Kindes verhindert
werden. Das bisher übliche Vorgehen ist insofern eine Sack-
gasse, als es zwar die perinatale Mortalität, jedoch nicht
die perinatale Morbidität zu senken vermag. Der Beginn
unseres Programms (20. Woche) wurde deshalb so früh
gewählt, weil wir der Ansicht sind, daß vorzeitige Schwan-
gerschaftsbeendigung nicht notwendigerweise die einzige
Konsequenz bei „Plazentarinsuffizienz" zu sein braucht.
Will man diese Notlösung vermeiden, müssen allerdings
zwei Voraussetzungen erfüllt sein: 1. Frühdiagnose der
Plazentafunktionsstörung und 2. rechtzeitige, langfristige
vorbeugende Maßnahmen. Die Hormondiagnostik bietet
nach unserer Meinung zur Zeit die einzige, in großem
Umfang praktikable Chance der Früherkennung der ge-
störten nutritiven Plazentafunktion. Alle anderen Para-
meter (Ultraschall, Fundusstand usw.) zeigen erst dann
pathologische Ergebnisse, wenn die Wachstumsverzöge-
rung des Feten schon manifest und es für eine konser-
vierende Behandlung zu spät ist.
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Das Gestationsalter wurde durch Messung des biparietalen
Kopfdurchmessers mittels Ultraschall in der 20. Woche
festgelegt. Die Hormonbefunde wurden in zwei Gruppen
unterteilt: normale und pathologische. Bei normalem
Hormonbefund wurde die Schwangere nur dann weiter
endokrinologisch überwacht, wenn gleichzeitig klinische
plazentare Risikofaktoren bestanden. Bei pathologischem
Hormonbefund wurde nach einer mehrwöchigen an-
schließenden Kontrollperiode nochmals selektiert. Die
Schwangeren mit gehäuften pathologischen Befunden
(etwa 10% der Gesamtgruppe) wurden in einem Intensiv-
programm weiter betreut. Hierüber wird gesondert be-
richtet. Die Hormonbefunde wurden in statistische Be-
ziehung gesetzt zum Geburtsgewicht der Kinder und zu
einem definierten „plazentaren Risiko" aus Anamnese
oder jetziger Gravidität. Es wurde dann eine interne
vergleichende Statistik von Früh- und Mangelgeburten
der Jahre 1973 bis 1975 erstellt. Dabei wurden Kinder
< 2700g in hypotrophe Reifgeborene, eutrophe Früh-
geborene und hypotrophe Frühgeborene klassifiziert.
Die Studie erbrachte folgende Ergebnisse:
1. Das von uns kürzlich beschriebene endokrinologische
\ Modell konnte erneut bestätigt werden. Von den
pathologischen Hormonbefunden entfielen 88,2% auf
pathologische Pregnandiolausscheidung (N = 105), nur
3,3% (N = 4) auf pathologische Östrogenausscheidung,
der Rest (N = 10) auf pathologische Östrogen- und
Pregnandiolausscheidung. Der endokrinologische Ge-
samtbefund war somit 119mal pathologisch (23,8%
aller Schwangerschaften, Tab. I).
Unserem Modell entsprechend finden sich die meisten
später hypotrophen Kinder in diesem frühen Schwan-
gerschaftsstadium noch in Risikogruppe II (10 von 15).
Für eine prozentuale Aufschlüsselung der hypotrophen
Neugeborenen in Abhängigkeit von der jeweiligen Risi-
kogruppe ist die Fallzahl zu gering. Jedoch ist bereits
zwischen der 20. und 27. Woche die gleiche Risikoten-
denz erkennbar, wie sie kürzlich für eine Gruppe von
222 Schwangeren aus späteren Schwangerschaftsstadien
beschrieben wurde: das Risiko der in trauterinen Mangel-
entwicklung wächst erheblich von Risikogruppe I (0,7%
hypotrophe Kinder) über II (10 Neugeborene von 105
hypotroph) und III (l Neugeborenes von 4 hypotroph)
nach Risikogruppe IV (4 Neugeborene von 10 hypo-
troph).
2. Es besteht ein sehr hoch signifikanter Zusammenhang
zwischen der Pregnandiolausscheidung nach unserer
Methodik und dem mittleren Geburtsgewicht der Neu-
geborenen (Tab. I). Dies ist ein weiterer Beweis, daß
die Pregnandiolausscheidung nach unserer Methodik
einen Frühparameter bei eingeschränkter nutritiver
Plazentafunktion repräsentiert, wie bereits kürzlich be-
richtet wurde. Mit Hilfe der Pregnandiolausscheidung
läßt sich „Plazentarinsuffizienz" schon zwischen der
20. und 27. Woche diagnostizieren.
3. Es wird ein „plazentares Risiko" definiert, das aus
plazentaren Risikofaktoren der Anamnese oder der
jetzigen Gravidität besteht (Tab. II). Bei pathologischem
Hormonbefund tritt „plazentares Risiko" sehr hoch
signifikant häufiger auf als bei normalem Hormonbe-
fund (Tab. I). Unter Einbeziehung der positiven Korre-
lation zwischen Pregnandiolausscheidung und mittlerem
Geburtsgewicht ist dadurch gleichzeitig bewiesen, daß
die genannten Faktoren des „plazentaren Risikos" tat-
sächlich plazentare Risikofaktoren im Sinne einer po-
tentiellen Beeinträchtigung der nutritiven Funktion
sind.
Bei „plazentarem Risiko" in der Anamnese und jetzt
normalem Hormonbefund wurde in 39 (95,1%) von 41
Fällen ein reifes, normalgewichtiges Kind geboren (eine
Frühgeburt, eine Mangelgeburt). Bei Fehlen eines
„plazentaren Risikos" und pathologischem Hormon-
befund wurde in 45 (93,7%) von 48 Fällen ein reifes,
normalgewichtiges Kind geboren (eine Frühgeburt,
zwei Mangelgeburten).
4. Nur in 3 (16,6%) von insgesamt 18 Fällen hypotropher
Neugeborener war der Hormonbefund im II. Trimenon
normal. Dagegen war der Hormonbefund in 14 (82,3%)
von insgesamt 17 Fällen eutropher Frühgeborener
normal.
5. Aus 2, 3 und 4 folgt, daß im Falle eines normalen Hor-
monbefundes zwischen der 20. und 27. Woche ein
plazentares Risiko und damit das Risiko der intrau-
terinen Wachstumsverzögerung relativ sicher ausge-
schlossen werden können. Bei pathologischem Hormon-
befund in der Vorsorgeperiode ist es erforderlich, nach
einer weiteren mehrwöchigen Kontrollperiode in der
30.-33. Woche diejenigen Risikofälle zu selektieren,
bei denen eine Bedrohung des Feten angenommen wer-
den muß. Letztere erfordern eine Intensivbetreuüng
bis zur Entbindung.
6. Das beschriebene System gestattet eine Frühdiagnose
von Störungen der nutritiven Plazentafunktion und
somit rechtzeitige, vorbeugende Maßnahmen. Darunter
verstehen wir neben der Behandlung einer eventuellen
klinischen Symptomatik vor allem eine allgemeine Ent-
lastung der Patientin schon vor der 30. Woche, falls er-
forderlich mit längeren Liegeperioden. Die Zahl der
hypotrophen Neugeborenen konnte dadurch an unserer
Klinik von 1973 bis 1975 deutlich gesenkt werden
(Tab. III). Die Zahl der eutrophen Frühgeborenen konnte
nicht gesenkt werden.
In der Frühgeburtenhäufigkeit des Jahres 1975 besteht
zwischen unserer Klinik (5,6%) und dem lokalen
Durchschnitt (ungefähr 4,2%) kein wesentlicher Unter-
schied. Jedoch ist der Unterschied in der Mangelge-
burtenhäufigkeit des Jahres 1975 zwischen unserer
Klinik (2,6%) und dem Hamburger Durchschnitt (un-
gefähr 5,5%) sehr hoch signifikant (P < 0,001).
7. Ein ambulantes endokrinologgches Vorsorgeprogramm
auf der Basis von 24-Stunden-Urin ist unter zwei Vor-
aussetzungen praktikabel: 1. Es muß eine sprachliche
Verständigung mit der Patientin möglich sein. 2. die
Patientin muß informiert und motiviert werden.
8. Wir meinen, daß das Ergebnis der vorliegenden Studie
ein starkes Argument zur Verlängerung der Mutter-
schutzfrist in der Bundesrepublik darstellt.
Schlüsselwörter: Endokrinologisches Vorsorgeprogramm, Gesamtöstrogene, intrauterine Wachstumsverzögerung, nutri-
tive Plazentafunktion, Pregnandiol.
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Resume
Valeur pronostique deladefinition combinee d'oestrogene
total et de pregnandiol des urines de 24 h., demontree a
l'aide de 500 grossesses dans le cadre d'un Programme
prophylactique endocrinologique au Deine trimestre
L'article present porte sur l'etude systematique de la
valeur pronostique des analyses hormonales au cours du
Ileme trimestre de la grossesse en ce qui concerne le
risque d'accouchement premature ou carenciel. Nous
referant a un exemple endocrinologique publie recemment,
nous avons effectue trois definitions combhrees
d'oestrogene total et de pregnandiol des urines de 24 h
entre la 20eme et la 27eme semaine de grossesse chez 500
fern m es enceintes «prises au hasard» depuis le debut de
1974. A notre connaissance c'est la premiere fois qu'a ete
etabli un Programme prophylactique endocrinologique
systematique pour ce stade precoce de la grossesse.
L'etude presente trace donc une voie dont le principe
differe de ce qui etait courant jusque la en medecine
perinatale. Comme on sait, les analyses hormonales ne
sont effectuees en general qu'apres la SOeme semaine de
grossesse et ne servent donc souvent qu'a decider s'il est
necessaire de terminer prematurement la grossesse. Ceci
permet, certes, d'empecher la möt embryonnaire intra-
uterine, mais non le retard de croissance intrauterine qui
entraine souvent des lesions cerebrales irreversibles chez
l'enfant. Le procede employe jusque lä s'avere donc
insuffisant dans la mesure oü il permet de faire baisser
seulement le taux de mortalite, mais non de morbidite
perinatale. Le debut de notre Programme (20eme semaine)
a ete fixe si tot parce que nous estimons que la fin
prematuree de la grossesse n'est pas necessairement la
seule mesure consequente a prendre en cas d'«insuffisance
placentaire». Toutefois, pour eviter cette solution
d'urgence, ü faut remplir au prealable les deux conditions
suivantes: 1. Diagnostic premature du trouble fonctionnel
placentaire et 2. mesures prophylactiques a long terme
appliquees a temps. Le diagnostic hormonal offre
actuellement a notre avis la seule chance largement
praticable du depistage precoce de la fonction placentaire
nutritive perturbee. Tous les autres parametres (ultra-son
etc...) ne donnent des resultats pathologiques que lorsque
le retard de croissance du foetus apparait de ja avec evidence
et qu'ü est trop tard pour appliquer un traitement
conservatif.
L'äge de gestation a ete fixe gräce a l'examen ultrasonique
(mesure du diametre cränien biparietal) dans la 20eme
semaine de grossesse. Les resultats hormonaux ont ete
divises en deux groupes: normaux et pathologiques. Dans
les premiers cas on n'a continue un controle endocrino-
logique que lorsque subsistaient des facteurs de risque
placentaires cliniques. Dans les seconds cas il a ete procede
ä une nouvelle selection apres plusieurs semaines
consecutives de surveillance. En cas de resultats
pathologiques repetes (10% environ de tout le groupe)
les femmes enceintes ont ete soignees dans le cadre d'un
Programme intensif qui est decrit a part.· Un rapport
statistique a ete etabli entre, d'une part, les resultats
hormonaux et, d'autre part, le poids des enfants a^la
naissance ainsi qu'un «risque placentaire» defini a paftir
de l'anamnese ou de la gravidite presente. Puis nous avons
effectue une statistique comparative interne des accouch-
ements prematures et carenciels pour les annees 1973 a
1975. Les enfants < 2700g ont ete classes en nouveaux-
nes «matures» hypotrophes, prematures eutrophes et
prematures hypotrophes.
L'etude a fourni les resultats suivants:
1. L'exemple endocrinologique que nous avons explicite
recemment a pu etre de nouveau confirme. Parmi les
resultats hormonaux pathologiques, 88,2% releverent
d'uneeliminationpathologiquede pregnandiol (N = 105),
3,3% seulement (N = 4) d'une elimination pathologique
d'oestrogene et le reste (N = 10) d'une elimination
pathologique d'oestrogene et de pregnandiol, c.ä.d. que
l'ensemble des resultats endocrinologiques a ete 119
fois pathologique (23,8% de toutes les grossesses,
Tab. I).
Correspondant a notre modele, la majorite des enfants
plus tard hypotrophes se trouvent encore dans le groupe
de risque II (10 sur 15) en ce stade precoce de grossesse.
Le nombre des nouveaux-nes hypotrophes concernes
dans notre etude est trop reduit pour permettre d'etablir
un pourcentage pour chaque groupe de risque respectif.
Toutefois, lameme tendance de risque est deja decelable
entre la 20emc et la 27eme semaine de grossesse ainsi
qu'elle a deja ete decrite recemment pour un groupe de
222 femmes enceintes en stade tardif de grossesse: le
risque de malnutrition intrauterine augmente consider-
ablement du groupe de risque I (0,7% des enfants
sont hypotrophes) aux groupes de risque II (10 enfants
hypotrophes sur 105 nouveaux-nes) et III (l enfant
hypotrophe sur 4 nouveaux-nes) jusqu'au groupe de
risque IV (4 enfants hypotrophes sur 10 nouveaux-
nes).
2. U existe un rapport tres significatif entre l'elimmation
de pregnandiol d'apres notre methode et le poids moyen
de naissance des nouveaux-nes (Tab. I). Ceci est une
preuve de plus qu'en accord avec notre methode
l'elimination de pregnandiol represente un parametre
precoce pour une fonction placentaire nutritive reduite
ainsi que nous l'avions relate recemment. L'analyse de
Felimination de pregnandiol permet de diagnostiquer
une «insuffisance placentaire» des la periode situee
entre la 20eme et la 27eme semaine de grossesse.
3. Nous avons defini un «risque placentaire» qui resulte
de facteurs de risque placentaires de Tanamnese ou de
la gravidite presente (Tab. H). En cas de resultats
hormonaux pathologiques, le «risque placentaire»
apparait beaucoup plus frequemment d'une fagon
statistiquement tres significative que dans les cas de
resultats normaux (Tab. I). Si on inclut la correlation
positive entre l'elimination de pregnandiol et le poids
moyen a la naissance, on prouve en meme temps que
les facteurs precites de «risque placentaire» sont
effectivement des facteurs de risque placentaires dans
le sens d'une restriction potentielle de la fonction nutri-
tive.
Dans les 39 des 41 (95,1%) cas de «risque placentaire»
de l'anamnese et de resultats hormonaux presentement
normaux, les nouveaux-nes ont eu un poids normal et
etaient «matures» (les deux autres cas ont ete un
accouchement premature et un accouchement carenciel).
Dans 45 des 48 (93,'7%) cas sans «risque placentaire»
mais avec resultats hormonaux pathologiques, les
nouveaux-nes ont eu un poids normal et etaient
J. Perinat. Med. 5 (1977)
144 Wolfrum et al., Combined assay of total estrogen and pregnanediol in urine
«matures» (les 3 autres cas ont consiste en un accouch-
ement premature et 2 accouchements carenciels).
4. Dans seulement 3 des 18 (16,6%) cas de nouveaux-nes
hypotrophes, les resultats hormonaux du Ileme trimestre
etaient normaux. Par contre, dans 14 des 17 (82,3%)
cas de prematures eutrophes, les resultats hormonaux
etaient normaux.
5. Des resultats 2, 3 et 4 il ressort qu'en cas de resultats
hormonaux normaux entre la 20eme et la 27eme·
semaine, un risque placentaire et, par lä, le risque du
retardement de croissance intra-uterine peuvent etre
exclus avec une certitude relativement absolue. Dans
les cas de resultats hormonaux pathologiques dans la
periode preventive, il est necessaire de selectionner
apres plusieurs semaines de controle, c.a.d. entre Ja
30eme et la 33eme semaine de grossesse, les cas de
risque qui fönt presager un risque pour le foetus. Ces
derniers exigent une surveillance intensive jusqu'a
l'accouchement.
6. Le Systeme decrit permet d'etablir un diagnostic precoce
de troubles de la fonction placentaire nutritive et de
prendre ainsi a temps des mesures prophylactiques qui
comprennent surtout, outre le traitement de symptomes
cliniques eventuels,un soulagement general de la patiente
des avant la 30eme semaine avec, si necessaire, de
longues periodes de repos allonge. Cela a permis
d'abaisser sensiblement le nombre des nouveaux-nes
hypotrophes a notre clinique entre 1973 et 1975
(Tab. III), mais non-celui des prematures eutrophes.
II n'existe pas de difference substantielle dans la
frequence des accouchements prematures de 1975 entre
notre clinique (5,6%) et la moyenne locale (4,2%
environ). Par contre, la difference de frequence des
accouchements carenciels en 1975 a ete tres forte
(P < 0,001) entre notre clinique (2,6%) et la moyenne
de Hambourg (5,5 % environ).
7. Un Programme prophylactique endocrinologique
en consultatiön externe base sur l'analyse des urines de
24 h. est praticable äux deux conditions suivantes: 1. II
faut pouvoir etre sür de bien se faire comprendre par la
parturiente. 2. Celle-ci doit etre införmee et «motivee».
8. Nous estimons que les resultats de Fetude presente
constituent un argument solide en faveur d'une
Prolongation du delaide protectiqn maternelle en RFA.
Mots-cles: Fonction placentaire nutritive, oestrogenes complets, pregnandiol, Programme prophylactique endocrinologique,
retardement de la croissance intra-uterine.
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